NYSE · CRL
Charles River Laboratories International, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CRL: Nov 04, 2026
Charles River Laboratories International, Inc. Common Stock is expected to report earnings on 11/04/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 7 analysts' forecasts, the consensus EPS forecast for the quarter is $2.98. The reported EPS for the same quarter last year was $2.43.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $2.98 | $3.13 | $2.94 | 7 |
| Dec 2026 | $3.30 | $3.44 | $3.12 | 6 |
| Mar 2027 | $2.66 | $3.13 | $2.33 | 5 |
| Jun 2027 | $3.28 | $3.37 | $3.23 | 5 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · BNK Invest · RTTNews · Fintel- Zacks · Oct 29, 9:00 AM EDTSolventum (SOLV) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseSolventum (SOLV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks · Oct 28, 9:00 AM EDTCharles River Laboratories (CRL) Earnings Expected to Grow: Should You Buy?Charles River (CRL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- BNK Invest · Oct 19, 12:08 PM EDTNoteworthy ETF Inflows: DFAS, IESC, SWKS, CRLLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Dimensional US Small Cap ETF (Symbol: DFAS) where we have detected an approximate $395.2 million dollar inflow — that's a 2.7% increase week over we
- Zacks · Oct 7, 10:40 AM EDTPGNY or CRL: Which Is the Better Value Stock Right Now?PGNY vs. CRL: Which Stock Is the Better Value Option?
- Zacks · Oct 7, 8:51 AM EDTCharles River Gains 75.8% in a Year: What's Driving the Rally?CRL shares have surged 75.8% in a year as RMS trends improve, AI-enabled testing expands and cash flow supports buybacks and investment.
- Zacks · Oct 6, 10:29 AM EDTIs It Prudent to Add Teleflex Stock to Your Portfolio Now?TFX's Vascular growth, Asia expansion and improved leverage support the outlook, but tariffs, input costs and margin pressure remain key risks.
- RTTNews · Oct 6, 3:37 AM EDTBiotech Stocks At 52-Week Highs – PCVX +31% On Phase 3 Results, INFU, ILMN +7%, CRL+7%, HTFL +5%(RTTNews) – The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.
- Fintel · Oct 2, 3:13 AM EDTCharles River Laboratories International Consensus Price Target Increased by 11.46% to $307.39The average one-year price target for Charles River Laboratories International (NYSE:CRL) (BMV:CRL) has been revised to $307.39 / share, up 11.46% from the prior estimate of $275.80 dated September 11, 2026. These figures represent aggregate analyst targets compiled by Fintel and
- BNK Invest · Oct 1, 4:38 PM EDTCharles River Laboratories International Now #430 Largest Company, Surpassing Tyler TechnologiesIn the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Charles River Laboratories International Inc. (Symbol: CRL) has taken over the #430 spot from Tyler Technologies, Inc. (Symbol: TYL), according to The Online Investor.
- Zacks · Sep 30, 8:40 AM EDTIs Aveanna Healthcare (AVAH) Stock Outpacing Its Medical Peers This Year?Here is how Aveanna Healthcare (AVAH) and Charles River Laboratories (CRL) have performed compared to their sector so far this year.
- MarketBeat · Sep 25, 9:02 PM EDTCharles River Targets 5%-7% Growth, $300M Savings in 2030 PlanThe 2 Worst Performing S&P 500 Stocks YTD: Buy, Sell, or Avoid?Charles River Laboratories International (NYSE:CRL) outlined a strategy to accelerate growth, expand margins and modernize its operations during its 2026 Investor Day, setting financial targets through 2030 that inclu
- Barchart · Sep 25, 12:46 PM EDTStocks Finish Mostly Lower as Bond Yields SoarThe S&P 500 Index ($SPX ) (SPY ) closed down by -0.02% on Thursday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.03%. December E-mini S&P futures (ESZ26 ) fell -0.10%, and December E-mini…
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Charles River Laboratories International, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.